Correction to: Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)

Ivan Foeldvari¹, Jens Klotsche^{2

3}, Gabriele Simonini⁴, Clive Edelsten⁵, Sheila T Angeles-Han⁶, Regitze Bangsgaard⁷, Joke de Boer⁸, Gabriele Brumm⁹, Rosa Bou Torrent^{10

11}, Tamas Constantin¹², Cinzia DeLibero¹³, Jesus Diaz^{14

15}, Valeria Maria Gerloni¹⁶, Margarida Guedes¹⁷, Arnd Heiligenhaus¹⁸, Kaisu Kotaniemi¹⁹, Sanna Leinonen¹⁹, Kirsten Minden^{2

20}, Vasco Miranda²¹, Elisabetta Miserocchi²², Susan Nielsen⁷, Martina Niewerth², Irene Pontikaki¹⁶, Carmen Garcia de Vicuna¹⁰, Carla Zilhao¹⁷, Steven Yeh²³, Jordi Anton^{10

11

24}

Affiliations

¹ Head of the Hamburg Centre for Pediatric and Adolescence Rheumatology Centre for Treatment of Scleroderma and Uveitis in Childhood and Adolescence Teaching Unit of the Asklepios Campus of the Semmelweis Medical School, Budapest An der Schön Klinik Hamburg Eilbek Dehnhaide, 120 22081, Hamburg, Germany. foeldvari@t-online.de.
² German Rheumatism Research Centre, 10117, Berlin, Germany.
³ Institute for Social Medicine, Epidemiology, and Health Economics, Charité Universitaetsmedizin Berlin, Berlin, Germany.
⁴ Rheumatology Unit- A. Meyer Children's Hospital- NEUROFARBA Department, University of Florence, Florence, Italy.
⁵ Department Rheumatology, Great Ormond Street Hospital, Great Ormond Street, London, UK.
⁶ Division of Rheumatology, Cincinnati Children's Hospital Medical Center, 3333 Burnett; Avenue, Cincinnati, OH 45229; Department of Pediatrics, University of Cincinnati, Cincinnati, OH, USA.
⁷ Department of Ophthalmology, Copenhagen University Hospital Glostrup/Rigshospitalet, Copenhagen, Denmark.
⁸ UMC Utrecht, Utrecht, Netherlands.
⁹ Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
¹⁰ Pediatric Rheumatology Department, Hospital Sant Joan de Déu, Barcelona, Spain.
¹¹ Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
¹² 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.
¹³ AOU Meyer, Florence, Italy.
¹⁴ Ophtalmology Department, Hospital Sant Pau, Barcelona, Spain.
¹⁵ Ophtalmology Department, Hospital Sant Joan de Déu, Barcelona, Spain.
¹⁶ Università di Milano - Istituto Gaetano Pini, Milan, Italy.
¹⁷ Pediatric Rheumatology Unit, Centro Hospitalar Universitário do Porto, Porto, Portugal.
¹⁸ St. Franziskus-Hospital Münster, Muenster, Germany.
¹⁹ Department of Ophthalmology, Helsinki University Hospital, Helsinki, Finland.
²⁰ Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Department of Rheumatology and Clinical Immunology, Berlin, Germany.
²¹ Pediatric Ophthalmologist at the Centro Hospitalar Universitario do Porto, Teaching Unit of the Abel Salazar Institute of Biomedical Sciences, Largo do Prof. Abel Salazar, 4099-001, Porto, Portugal.
²² Ocular Immunology and Uveitis Service, Department of Ophthalmology, San Raffaele Scientific, Institute, Via Olgettina 60, 20122, Milan, Italy.
²³ Emory Clinic, Atlanta, USA.
²⁴ Department of Surgery and Surgery Specializations, Universitat de Barcelona, Barcelona, Spain.

PMID: 32046749
PMCID: PMC7011209
DOI: 10.1186/s12969-019-0396-4

Published Erratum

Correction to: Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)

Ivan Foeldvari et al. Pediatr Rheumatol Online J. 2020.

. 2020 Feb 11;18(1):14.

doi: 10.1186/s12969-019-0396-4.

Authors

Affiliations

¹ Head of the Hamburg Centre for Pediatric and Adolescence Rheumatology Centre for Treatment of Scleroderma and Uveitis in Childhood and Adolescence Teaching Unit of the Asklepios Campus of the Semmelweis Medical School, Budapest An der Schön Klinik Hamburg Eilbek Dehnhaide, 120 22081, Hamburg, Germany. foeldvari@t-online.de.
² German Rheumatism Research Centre, 10117, Berlin, Germany.
³ Institute for Social Medicine, Epidemiology, and Health Economics, Charité Universitaetsmedizin Berlin, Berlin, Germany.
⁴ Rheumatology Unit- A. Meyer Children's Hospital- NEUROFARBA Department, University of Florence, Florence, Italy.
⁵ Department Rheumatology, Great Ormond Street Hospital, Great Ormond Street, London, UK.
⁶ Division of Rheumatology, Cincinnati Children's Hospital Medical Center, 3333 Burnett; Avenue, Cincinnati, OH 45229; Department of Pediatrics, University of Cincinnati, Cincinnati, OH, USA.
⁷ Department of Ophthalmology, Copenhagen University Hospital Glostrup/Rigshospitalet, Copenhagen, Denmark.
⁸ UMC Utrecht, Utrecht, Netherlands.
⁹ Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
¹⁰ Pediatric Rheumatology Department, Hospital Sant Joan de Déu, Barcelona, Spain.
¹¹ Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
¹² 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.
¹³ AOU Meyer, Florence, Italy.
¹⁴ Ophtalmology Department, Hospital Sant Pau, Barcelona, Spain.
¹⁵ Ophtalmology Department, Hospital Sant Joan de Déu, Barcelona, Spain.
¹⁶ Università di Milano - Istituto Gaetano Pini, Milan, Italy.
¹⁷ Pediatric Rheumatology Unit, Centro Hospitalar Universitário do Porto, Porto, Portugal.
¹⁸ St. Franziskus-Hospital Münster, Muenster, Germany.
¹⁹ Department of Ophthalmology, Helsinki University Hospital, Helsinki, Finland.
²⁰ Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Department of Rheumatology and Clinical Immunology, Berlin, Germany.
²¹ Pediatric Ophthalmologist at the Centro Hospitalar Universitario do Porto, Teaching Unit of the Abel Salazar Institute of Biomedical Sciences, Largo do Prof. Abel Salazar, 4099-001, Porto, Portugal.
²² Ocular Immunology and Uveitis Service, Department of Ophthalmology, San Raffaele Scientific, Institute, Via Olgettina 60, 20122, Milan, Italy.
²³ Emory Clinic, Atlanta, USA.
²⁴ Department of Surgery and Surgery Specializations, Universitat de Barcelona, Barcelona, Spain.

PMID: 32046749
PMCID: PMC7011209
DOI: 10.1186/s12969-019-0396-4

Abstract

Following publication of the original article [1], we have been notified that the author Joan Calzada should not have been included to the team of authors. The authors' team, thus, should be as follows.

PubMed Disclaimer

Erratum for

Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC).
Foeldvari I, Klotsche J, Simonini G, Edelsten C, Angeles-Han ST, Bangsgaard R, de Boer J, Brumm G, Torrent RB, Constantin T, DeLibero C, Diaz J, Gerloni VM, Guedes M, Heiligenhaus A, Kotaniemi K, Leinonen S, Minden K, Miranda V, Miserocchi E, Nielsen S, Niewerth M, Pontikaki I, de Vicuna CG, Zilhao C, Yeh S, Anton J. Foeldvari I, et al. Pediatr Rheumatol Online J. 2019 Oct 1;17(1):66. doi: 10.1186/s12969-019-0345-2. Pediatr Rheumatol Online J. 2019. PMID: 31575380 Free PMC article.

References

1. Foeldvari I, et al. Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC) Pediatr Rheumatol Online J. 2019;17:66. doi: 10.1186/s12969-019-0345-2. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)

Affiliations

Correction to: Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)

Authors

Affiliations

Abstract

Erratum for

References

Publication types

LinkOut - more resources

Full Text Sources